Trial: 201907060

A Phase I Study of PD-1 Inhibition with TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Phase

I

Principal Investigator

Markovina, Stephanie

Disease Site

Corpus Uteri

Learn more about this study at: clinicaltrials.gov